Resveratrol is considered anti-inflammatory and consistently comes up with big promises in relation to endometriosis. What does the science really show?
Many women with endometriosis are looking for natural ways to take care of themselves. Resveratrol comes up again and again in this context. Let's take an honest look at what science shows, where it is promising, and where questions still remain.
Endometriosis is a chronic inflammatory disease in which tissue similar to the uterine lining grows outside the uterus. Because inflammation, oxidative stress, the formation of new blood vessels, and estrogen play a central role, a plant compound like trans-resveratrol is scientifically interesting. It targets precisely these processes. In this article, we evaluate the study situation honestly and without overpromising. Important note: Trans-resveratrol is not a medication or treatment for endometriosis, and this text does not replace a medical consultation.
Why the trans-form is crucial
One point often overlooked: Not all resveratrol is the same. Resveratrol naturally has very low bioavailability. It is rapidly metabolized in the intestine and liver, so only a small portion reaches the bloodstream as a free, active substance.² The trans-form is the stable and biologically relevant variant. It is the one most commonly used in research, which is why the form in which resveratrol is present is fundamental for a meaningful classification of studies.
What research shows about mechanisms
The theoretical background is well-established. In laboratory and animal studies, resveratrol targets precisely the mechanisms that play a role in endometriosis: It affects inflammatory processes, oxidative stress, cell growth, and the formation of new blood vessels.³
A systematic review summarizes that resveratrol may influence the growth of endometriosis-like tissue in models by inhibiting cell proliferation and promoting the death of altered cells. In animal models, resveratrol also reduced the size of endometriotic lesions and lowered pro-inflammatory and pro-angiogenic mediators.⁴
What human studies show
It gets interesting with human studies, because here the picture is more nuanced than often portrayed. Two randomized studies with higher dosages (around 400 to 800 mg over approximately twelve weeks, in addition to standard hormonal therapy) found that resveratrol significantly reduced inflammatory and angiogenic markers in endometrial tissue, specifically VEGF and TNF-alpha.⁵ These are measurable biological effects on precisely the mechanisms that are central to endometriosis.
Measurable biological effects
Around 400 to 800 mg over twelve weeks reduced inflammatory and vascular markers like VEGF and TNF-alpha in tissue.
Pain open to question
At only 40 mg over six weeks, resveratrol was not better than a placebo for pain. Experts attribute this to the short duration.
An older, lower-dose study showed no advantage over placebo for pain. However, the study duration was only six weeks, and precisely this short duration is cited in expert reviews as the probable explanation for the lack of results.⁶ Thus, the data on pain remains inconclusive. On a biological level, however, the higher-dose studies point in a consistent direction.
The form and dose are decisive. Higher-dose trans-resveratrol shows measurable effects on inflammatory markers in humans, while the benefit for pain still needs further investigation.
Doctor-developed for your cycle
Cycle+ contains trans-resveratrol as one of several botanical ingredients, alongside myo-inositol, rhodiola, and others. The formula is intended as general cycle support and is loved by thousands of women.
€75,00
The duo for hormonal imbalance
Hormonic Base provides you daily with 16 essential active ingredients such as zinc, selenium, or vitamin D, while Cycle+ delivers targeted botanicals for your cycle health. Doctor-developed, produced in Austria.
Frequently Asked Questions about Resveratrol and Endometriosis
Does resveratrol help with endometriosis?
Which foods contain resveratrol?
Ist Resveratrol als Nahrungsergänzung sinnvoll bei Endometriose?
Warum wirken Laborstudien oft positiver als Studien am Menschen?
Scientific Sources
- Yavuz S, Aydin NE, et al. (2017). The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial. Journal of the Endocrine Society, 1(4), 359-369. doi:10.1210/js.2017-00053
- Sienko A, et al. (2024). The effect of two anti-inflammatory dietary components, omega-3 and resveratrol, on endometriosis: a systematic review. Ginekologia Polska, 95(7), 573-583.
- Ozcan Cenksoy P, et al. (2023). Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis. International Journal of Women's Health, 15. doi:10.2147/IJWH.S404660
- Brichant G, et al. (2022). Impact of curcumin, quercetin, or resveratrol on the pathophysiology of endometriosis: A systematic review. Phytotherapy Research, 36(7). doi:10.1002/ptr.7464
- Becker CM, et al. (2022). ESHRE guideline: endometriosis. Human Reproduction Open, 2022(2), hoac009. doi:10.1093/hropen/hoac009
You might also be interested in this.

Endometriosis affects one in ten women and is often diagnosed late. Learn why it is so heavily dependent on estrogen and progesterone and what conventional and natural approaches can help.

In the lab, quercetin shows strong effects against endometriosis cells, and initial human studies with quercetin, curcumin, and NAC are encouraging. What the research truly shows, honestly assessed.

Zinc, Vitamins C and E for Endometriosis: What Studies on Oxidative Stress and Pain Show, with Honest Classification and Practical Tips for Everyday Life.










